Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Advanced lung cancer patients' group.
- Who it may be relevant to
- Registry conditions: Lung Cancer Stage IV. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Demographic, Clinical, Histological and Molecular Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohort, an Observational Cohort Study: Lung Cancer ID Study
Overview
The distribution of demographic, clinical, radiological, pathological and molecular characteristics of lung cancer at the time of diagnosis, as well as preferential association between elements of those domains, have not been specifically studied in Italy. The aim of the present project is to assess, in a systematic fashion, the demographic, clinical, radiological, pathological and molecular characteristics of advanced lung cancer at the time of diagnosis in a large Italian cohort of consecutive patients referred to two tertiary referral centers.
Interventions
- Other Advanced lung cancer patients' group
Evaluation of the demographic, clinical, histological and molecular characteristics of advanced lung cancer at the time of Diagnosis
Primary outcome measures
- Distribution of histologic subtypes [Time frame: 24 months]
Secondary outcome measures (3)
- Distribution of histologic subtypes according to clinical and radiological characteristics [Time frame: 24 months]
- Molecular profiling [Time frame: 24 months]
- Time to diagnosis [Time frame: 24 months]
Eligibility criteria
Inclusion criteria
- Age >18 years
- Suspicion of lung cancer based on imaging (CT and/or PET/CT)
- Indication to a biopsy for diagnosis, staging and/or molecular profiling
Exclusion criteria
- Inability or unwillingness to provide a written informed consent
- ECOG performance status (>3) which makes a tissue diagnosis unfeasible
- ASA 4 status
- TNM Stage I-III
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Italy · 3 centers
- Interventional Pulmonology Division - Fondazione Policlinico Universitario A. Gemelli IRCC — Roma
- Istituto Nazionale Tumori Regina Elena — Roma
- Medical Oncology Division - Fondazione Policlinico Universitario Agostino Gemelli IRCCS — Roma
Identifiers
NCT: NCT06076005 · 5937